Assessment of solid components of borderline ovarian tumor and stage I carcinoma: added value of combined diffusion- and perfusion-weighted magnetic resonance imaging
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: We sought to determine the value of combining diffusion-weighted (DW) and perfusion-weighted (PW) sequences with a conventional magnetic resonance (MR) sequence to assess solid components of borderline ovarian tumors (BOTs) and stage I carcinomas. Methods: Conventional, DW, and PW sequences in the tumor imaging studies of 70 patients (BOTs, n=38; stage I carcinomas, n=32) who underwent surgery with pathologic correlation were assessed. Two independent radiologists calculated the parameters apparent diffusion coefficient (ADC), Ktrans (vessel permeability), and Ve (cell density) for the solid components. The distribution on conventional MR sequence and mean, standard deviation, and 95% confidence interval of each DW and PW parameter were calculated. The inter-observer agreement among the two radiologists was assessed. Area under the receiver operating characteristic curve (AUC) and multivariate logistic regression were performed to compare the effectiveness of DW and PW sequences for average values and to characterize the diagnostic performance of combined DW and PW sequences. Results: There were excellent agreements for DW and PW parameters between radiologists. The distributions of ADC, Ktrans and Ve values were significantly different between BOTs and stage I carcinomas, yielding AUCs of 0.58 and 0.68, 0.78 and 0.82, and 0.70 and 0.72, respectively, with ADC yielding the lowest diagnostic performance. The AUCs of the DW, PW, and combined PW and DW sequences were 0.71±0.05, 0.80±0.05, and 0.85±0.05, respectively. Conclusion: Combining PW and DW sequences to a conventional sequence potentially improves the diagnostic accuracy in the differentiation of BOTs and stage I carcinomas.
Abstract
Background: We sought to determine the value of combining diffusion-weighted (DW) and perfusion-weighted (PW) sequences with a conventional magnetic resonance (MR) sequence to assess solid components of borderline ovarian tumors (BOTs) and stage I carcinomas. Methods: Conventional, DW, and PW sequences in the tumor imaging studies of 70 patients (BOTs, n=38; stage I carcinomas, n=32) who underwent surgery with pathologic correlation were assessed. Two independent radiologists calculated the parameters apparent diffusion coefficient (ADC), Ktrans (vessel permeability), and Ve (cell density) for the solid components. The distribution on conventional MR sequence and mean, standard deviation, and 95% confidence interval of each DW and PW parameter were calculated. The inter-observer agreement among the two radiologists was assessed. Area under the receiver operating characteristic curve (AUC) and multivariate logistic regression were performed to compare the effectiveness of DW and PW sequences for average values and to characterize the diagnostic performance of combined DW and PW sequences. Results: There were excellent agreements for DW and PW parameters between radiologists. The distributions of ADC, Ktrans and Ve values were significantly different between BOTs and stage I carcinomas, yielding AUCs of 0.58 and 0.68, 0.78 and 0.82, and 0.70 and 0.72, respectively, with ADC yielding the lowest diagnostic performance. The AUCs of the DW, PW, and combined PW and DW sequences were 0.71±0.05, 0.80±0.05, and 0.85±0.05, respectively. Conclusion: Combining PW and DW sequences to a conventional sequence potentially improves the diagnostic accuracy in the differentiation of BOTs and stage I carcinomas.
참고문헌 (26)
- Aref M, "Spatial and temporal resolution effects on dynamic contrast-enhanced magnetic resonance mammography", Magn Reson Imaging, 25, pp.14~34 (2007)
- Cuenod CA, "Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment", Abdom Imaging, 31, pp.188~193 (2006)
- deSouza NM, "Borderline tumors of the ovary: CT and MRI features and tumor markers in differentiation from stage I disease", AJR Am J Roentgenol, 184, pp.999~1003 (2005)
- Emoto M, "Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density", Cancer, 80, pp.899~907 (1997)
- Fujii S, "Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions", J Magn Reson Imaging, 28, pp.1149~1156 (2008)
- Hricak H, "Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis", Radiology, 214, pp.39~46 (2000)
- Kozlowski P, "Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology", J Magn Reson Imaging, 24, pp.108~113 (2006)
- Landis JR, "An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers", Biometrics, 33, pp.363~374 (1977)
- Lee EJ, "Is CA-125 an additional help to radiologic findings for differentiation borderline ovarian tumor from stage I carcinoma?", Acta Radiol, 52, pp.458~462 (2011)
- Metz CE, "Gains in accuracy from replicated readings of diagnostic images: prediction and assessment in terms of ROC analysis", Med Decis Making, 12, pp.60~75 (1992)
- Metz CE, "“Proper” binormal ROC curves: theory and maximum-likelihood estimation", J Math Psychol, 43, pp.1~33 (1999)
- Moore RG, "How do you distinguish a malignant pelvic mass from a benign pelvic mass? Imaging, biomarkers, or none of the above", J Clin Oncol, 25, pp.4159~4161 (2007)
- Nakayama T, "Diffusion-weighted echo-planar MR imaging and ADC mapping in the differential diagnosis of ovarian cystic masses: usefulness of detecting keratinoid substances in mature cystic teratomas", J Magn Reson Imaging, 22, pp.271~278 (2005)
- Timmerman D, "Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group", Ultrasound Obstet Gynecol, 16, pp.500~505 (2000)
- Sohaib SA, "Characterization of adnexal mass lesions on MR imaging", AJR Am J Roentgenol, 180, pp.1297~1304 (2003)
- Thomassin-Naggara I, "Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors", J Magn Reson Imaging, 28, pp.111~120 (2008)
- Thomassin-Naggara I, "Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis", Radiology, 248, pp.148~159 (2008)
- Thomassin-Naggara I, "Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses", Eur Radiol, 19, pp.1544~1552 (2009)
- Nishida N, "Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma", Cancer, 101, pp.1364~1374 (2004)
- Orre M, "Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary", Br J Cancer, 77, pp.2204~2209 (1998)
- Oto A, "Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging", Radiology, 257, pp.715~723 (2010)
- Padhani AR, "Perfusion MR imaging of extracranial tumor angiogenesis", Top Magn Reson Imaging, 15, pp.41~57 (2004)
- Song T, "Optimal k-space sampling for dynamic contrast-enhanced MRI with an application to MR renography", Magn Reson Med, 61, pp.1242~1248 (2009)
- Takemori M, "Clinical evaluation of MRI in the diagnosis of borderline ovarian tumors", Acta Obstet Gynecol Scand, 81, pp.157~161 (2002)
- Takeuchi M, "Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses", J Comput Assist Tomogr, 34, pp.173~176 (2010)
- Yankeelov TE, "Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results", Magn Reson Imaging, 25, pp.1~13 (2007)